Worsening diabetic retinopathy : Changes in vision, particularly in patients with pre-existing diabetic retinopathy, should be closely monitored
The causes can vary, including autoimmune diseases, infections, or trauma
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated an average weight loss of 15% in clinical trials when combined with lifestyle modification
250 mg fehr eper kivonat 10:1 arnyban megfelel 2500 mg fehr eper pornak
Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
To improve the likelihood of a successful taper and minimize withdrawal symptoms, it is important that the opioid tapering schedule is agreed upon by the patient